Associated Papers
Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome.
Montellier E et al.
Ebiomedicine, 2026
A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome.
Fortuno C et al.
Genome Medicine, 2025
Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome.
Montellier E et al.
Iscience, 2024
Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types.
Sasaki K et al.
Scientific Reports, 2023
TP53_PROF: a machine learning model to predict impact of missense mutations in TP53.
Ben-Cohen G et al.
Briefings in Bioinformatics, 2022
The dark side of histones: genomic organization and role of oncohistones in cancer.
Amatori S et al.
Clinical Epigenetics, 2021
Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
Jafrin S et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2020
Genetic variation of acquired structural chromosomal aberrations.
Vodicka P et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis, 2018
Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore.
Wong ESY et al.
Npj Genomic Medicine, 2016
Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women.
Lajin B et al.
Breast Cancer Research and Treatment, 2013
A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects.
Sagne C et al.
Cell Death & Disease, 2013
Association between polymorphisms in the genes for tumor suppressor protein p53 and its regulator NAD(P)H: quinone oxidoreductase 1 (NQO1) and schizophrenia in a Syrian study cohort.
Lajin B et al.
Archives of Medical Research, 2013
Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer.
Hofstetter G et al.
Oncogene, 2010
Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis.
Hu Z et al.
Breast Cancer Research and Treatment, 2010
BCL6: somatic mutations and expression in early-stage chronic lymphocytic leukemia.
Jantus Lewintre E et al.
Leukemia & Lymphoma, 2009
Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
Polakova V et al.
Human Mutation, 2009
Predicting the oncogenicity of missense mutations reported in the International Agency for Cancer Research (IARC) mutation database on p53.
Gorlov IP et al.
Human Mutation, 2005
Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.
Huang XE et al.
Breast Cancer (tokyo, Japan), 2003
p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status.
McGregor JM et al.
Oncogene, 1997